Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAcer Gdr Reg S Regulatory News (ACID)

Share Price Information for Acer Gdr Reg S (ACID)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: -6.00 (-100.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 7.00
ACID Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

To announce the Company's sales and information

8 Sep 2023 10:20

RNS Number : 8766L
Acer Incorporated
08 September 2023
 

No.1

Acer Inc. Announces Un-Audited Monthly Sales Ended August. 31, 2023

 

Item

Revenue (Unit: NTD1,000)

Current Month

21,687,117

Same Month Last Year

20,241,042

Amount Difference

1,446,075

YoY (%)

7.14

Current Year Accumulated Revenue

150,101,536

Last Year Accumulated Revenue

188,420,165

Amount Difference

-38,318,629

YoY Accumulated (%)

-20.34

No.2Subject: (Supplemental)To announce the timeline of releasing Acerpure Inc.'s Shares to Acer Shareholders for the Process of API IPO Plan

Date of events: 2023/09/08

Contents:

1.Date of occurrence of the event:2023/09/08

2.Company name:Acer Inc.

3.Relationship to the Company (please enter "head office" or

"subsidiaries"):head office

4.Reciprocal shareholding ratios:N.A.

5.Cause of occurrence:

For the process of having the shares of Acerpure Inc. ("API"), the

Company's subsidiary, be listed and traded on Taiwan Stock Exchange or

Taipei Exchange, the Company will release 7,500,000 API shares in

accordance with the board resolution.

6.Countermeasures:None

7.Any other matters that need to be specified (the information disclosure

also meets the requirements of Article 7, subparagraph 9 of the Securities

and Exchange Act Enforcement Rules, which brings forth a significant impact

on shareholders rights or the price of the securities on public companies.):

(1)To comply with IPO relevant regulations, to protect the rights and

interest of the shareholder of the Company, and to balance the cost

and expense of related process, according to the board resolution made

on August 3rd , 2023, the Company will sell 7,500,000 API's common

shares to the Company's shareholder with the amount of NT$13.5 per

share. Provided that if the shareholders of the Company waive the rights

of subscription, or the aggregate amount of subscription is less than

7,500,000, the Chairman is authorized to designate specific persons

for the purchase of the common shares of API at the same price

aforementioned.

(2)The shareholders who are recorded in the Company's shareholders register

on the book closure date before the shares release process will be

qualified to purchase API's common shares with calculating the percentage

of whose holding of the Company's common shares, and each share of the

Company will be granted to purchase 0.0024607 API's common share (will

be rounded down to the nearest whole number without any discretion).

(3)Shareholders may apply to the Company's stock affairs office for

combination of their shares before the end of the payment date for the

transaction. Shareholders not applying for combination within the period

or whose combined shares are less than one API's common share will be

deemed to waive whose rights of purchase.

(4)Shareholders who own the Company's share after the book closure date,

before the end of the payment date for the purchase, will be granted to

apply for the purchase by submitting whose certificate of stock

ownership to the Company's stock affairs office. The Company will deem

the applicant as the specific persons and accept whose application of

purchase in accordance with the conditions herein.

(5)In accordance with conditions herein, any shareholders who have rights

to purchase more than 1,000 API's common shares, will be provided with

the notice of the payment by an ordinary mail.

(6)As to the shareholder whose rights of purchase are less than 1,000 API's

common shares, the Company will not provide any notice individually

besides this announcement, such shareholders shall contact to the

Company's stock affairs office directly for payment related information.

(7)Planned agenda for the transaction is as follows:

a. The payment term is from September 27, 2023 to October 27, 2023.

b. The end date of the application for the combination of the shares

is on October 27, 2023.

c. The end date of the application for the shareholders who own

the Company's share after the book closure date is on

October 27, 2023.

(8)Since the API's common shares will be transferred to the shareholders

from the Company, any shareholder who made the payment has not yet

accomplished the share transfer procedure. API will send and provide

the notice of share transfer procedure after the payment term, the

shareholders who received such notice shall submit the documents

specified in the notice to the API's shareholder services agent for

the procedure of share transfer.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFIFLAADITIIV
Date   Source Headline
18th Apr 202410:15 amRNSTo announce the Company's information
11th Apr 202410:23 amRNSTo announce the Company's information
10th Apr 202410:16 amRNSUn-Audited Monthly Sales Ended Mar. 31, 2024
2nd Apr 20247:00 amRNSTo Announce the Company's Infomation
14th Mar 202410:01 amRNSTo announce the Company's information
7th Mar 20249:45 amRNSUn-Audited Monthly Sales Ended Feb. 29, 2024
26th Feb 20249:38 amRNSTo announce the Company's information
19th Feb 20249:11 amRNSTo announce the Company's information
7th Feb 20248:03 amRNSUn-Audited Monthly Sales Ended Jan. 31, 2024
17th Jan 202410:05 amRNSTo announce the Company's information
8th Jan 20249:24 amRNSUn-Audited Monthly Sales Ended Dec. 31, 2023
27th Dec 20237:00 amRNSTo announce the Company's information
11th Dec 20239:44 amRNSUn-Audited Monthly Sales Ended Nov. 30, 2023
9th Nov 20239:21 amRNSUn-Audited Monthly Sales Ended Oct. 31, 2023
2nd Nov 20239:15 amRNSTo announce the Company's information
24th Oct 20232:34 pmRNSTo announce the Company's information
16th Oct 20237:24 amRNSTo announce the Company's information
11th Oct 202310:36 amRNSUn-Audited Monthly Sales Ended Sep. 30, 2023
26th Sep 202310:07 amRNSTo announce the Company's information
8th Sep 202310:20 amRNSTo announce the Company's sales and information
5th Sep 20237:10 amRNSTo announce the Company's information
23rd Aug 202310:17 amRNSTo announce the Company's information
9th Aug 202310:13 amRNSUn-Audited Monthly Sales Ended July 31, 2023
8th Aug 202312:16 pmRNSTo announce the Company's information
3rd Aug 20231:09 pmRNSTo announce the Company's information
10th Jul 20237:00 amRNSUn-Audited Monthly Sales Ended June 30, 2023
29th Jun 202310:54 amRNSTo announce the Company's information
8th Jun 202310:17 amRNSUn-Audited Monthly Sales Ended May 31, 2023
7th Jun 20237:00 amRNSTo announce the Company's information
9th May 202310:35 amRNSTo announce the Company's info and Monthly Revenue
4th May 202311:14 amRNSTo announce the Company's information
24th Apr 202310:32 amRNSTo announce the Company's information
11th Apr 202311:05 amRNSTo announce the Company's info and Monthly Revenue
11th Apr 20237:00 amRNSTo announce the Company's information
31st Mar 202310:13 amRNSTo announce the Company's information
16th Mar 202310:24 amRNSTo announce the Company's information
10th Mar 20239:06 amRNSUn-Audited Monthly Sales Ended Feb. 28, 2023
8th Mar 20232:23 pmRNSTo announce the Company's information
2nd Mar 20239:05 amRNSTo announce the Company's information
10th Feb 20239:05 amRNSUn-Audited Monthly Sales Ended Jan. 31, 2023
9th Jan 202310:07 amRNSUn-Audited Monthly Sales Ended Dec. 31, 2022
4th Jan 20239:56 amRNSTo announce the Company's information
16th Dec 20229:12 amRNSTo announce the Company's information
9th Dec 20229:06 amRNSUn-Audited Monthly Sales Ended Nov. 30, 2022
8th Dec 20229:20 amRNSTo announce the Company's information
5th Dec 20229:13 amRNSTo announce the Company's information
29th Nov 202211:14 amRNSTo announce the Company's information
9th Nov 20229:23 amRNSUn-Audited Monthly Sales Ended Oct. 31, 2022
8th Nov 20228:50 amRNSTo announce the Company's information
3rd Nov 202210:04 amRNSTo announce the Company's information

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.